leisure time -WSS

leisure time

author：hotspot 2025-10-02 15:43:32 - browse：478

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Judge orders hearing on Trump's motion to disqualify Fulton County DA

WSS

American TikTok star stuck in Dubai for months following rental car altercation

Many immigrants are left out of maternal health programs

House GOP plan to stem drug shortages differs from Democrats’

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

HCA says smaller share of spending going to labor

Poland's lawmakers approve a divisive law on Russian influence

entertainment

leisure time

knowledge

Supreme Court strikes down use of affirmative action

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Wildfire smoke exposes gaps in outdoor worker protections

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

How to save PrEP access — and even expand it

Medicare proceeds with plan to claw back hospital funds

ChatGPT in medicine: STAT answers readers' burning questions

Medicare must police algorithms in Medicare Advantage, Dems say

Cancer drug shortages should be causing more outrage

Europe is fastest

focus

Coloradans with cystic fibrosis could lose access to Trikafta

'Weather

Poland's lawmakers approve a divisive law on Russian influence

Travis Kelce and the trap of celebrity vaccine endorsements

'Weather

Poland's lawmakers approve a divisive law on Russian influence

hotspot

focus

explore

entertainment